13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001841857
Total reported value
$157.4M
$157.4M
54 檔
16.1%
In Q1 2025, CM Management, LLC's U.S. equity holdings reached a combined market value of $157.4M, distributed across 54 disclosed stock positions.
In Q1 2025, CM Management, LLC displayed an active expansion posture, initiating 54 new positions and adding to 0 existing holdings, outstripping position reductions.
In terms of portfolio concentration, the top 5 core holdings (including ALCO, TGB, RLGT) accounted for 16.1% of total reported equity market value during Q1 2025.
Top New Position Initiated
ALCO
市值: $6.7M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALCO | Alico Inc | Stock-Other | 6.75% | -1.64% | — | |
| 2 | TGB | Taseko Mines LTD | Stock-Other | 5.51% | — | — | |
| 3 | RLGT | Radiant Logistics Inc | Stock-Other | 4.79% | -0.10% | — | |
| 4 | RIGL | Rigel Pharmaceuticals Inc | Stock-Other | 4.52% | +0.90% | +3.09% | |
| 5 | PLPC | Preformed Line Products Co | Stock-Other | 3.94% | — | +3.70% | |
| 6 | AM6 | Amicus Therapeutics Inc | Stock-Other | 3.69% | — | — | |
| 7 | TALO | Talos Energy Inc | Stock-Other | 3.42% | +0.62% | NEW | |
| 8 | NMRK | Newmark Group Inc-class A | Stock-Other | 3.36% | -0.46% | -8.33% | |
| 9 | BGC | Bgc Group Inc-a | Stock-Financials | 2.76% | -0.62% | +9.09% | |
| 10 | PD | Pagerduty Inc | Stock-Other | 2.75% | +0.23% | — | |
| 11 | FCX | Freeport-mcmoran Inc | Stock-Materials | 2.66% | — | +40.00% | |
| 12 | INTT | Intest CORP | Stock-Other | 2.63% | -3.77% | EXIT | |
| 13 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 2.49% | — | +33.33% | |
| 14 | RBCAA | Republic Bancorp Inc-class A | Stock-Other | 2.24% | -0.05% | — | |
| 15 | OGN | Organon & Co | Stock-Healthcare | 2.24% | +0.36% | — | |
| 16 | CGAU | Centerra Gold Inc | Stock-Other | 2.23% | — | — | |
| 17 | ARKO | Arko CORP | Stock-Other | 2.21% | +0.05% | — | |
| 18 | PK | Park Hotels & Resorts Inc | Stock-Real Estate | 2.15% | -0.39% | +33.33% | |
| 19 | THFF | First Financial CORP | Stock-Other | 2.09% | -1.59% | EXIT | |
| 20 | CLPT | Clearpoint Neuro Inc | Stock-Other | 2.09% | +0.28% | -39.66% | |
| 21 | ARKR | Ark Restaurants CORP | Stock-Other | 2.03% | -0.39% | — | |
| 22 | SABR | Sabre CORP | Stock-Tech | 1.98% | -0.02% | — | |
| 23 | BB3 | Brookline Bancorp Inc | Stock-Other | 1.97% | — | — | |
| 24 | VTRS | Viatris Inc | Stock-Healthcare | 1.97% | -0.21% | +12.50% | |
| 25 | EOLS | Evolus Inc | Stock-Other | 1.81% | +0.39% | — | |
| 26 | CHRS | Coherus Oncology Inc | Stock-Other | 1.74% | -1.10% | +4.76% | |
| 27 | IOVA | Iovance Biotherapeutics Inc | Stock-Other | 1.67% | -0.13% | +66.67% | |
| 28 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 1.62% | — | +114.29% | |
| 29 | CYTK | Cytokinetics Inc | Stock-Healthcare | 1.62% | — | — | |
| 30 | AVIR | Atea Pharmaceuticals Inc | Stock-Other | 1.50% | -0.55% | +66.67% | |
| 31 | COHU | Cohu Inc | Stock-Other | 1.48% | — | +42.86% | |
| 32 | HRTX | Heron Therapeutics Inc | Stock-Other | 1.33% | -0.40% | -14.29% | |
| 33 | COYA | Coya Therapeutics Inc | Stock-Other | 1.30% | +0.25% | +25.00% | |
| 34 | XOMA | Xoma Royalty Corporation | Stock-Other | 1.28% | -1.05% | EXIT | |
| 35 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 1.25% | — | +7.14% | |
| 36 | SVC | Service Properties Trust | Stock-Other | 1.18% | -0.19% | — | |
| 37 | DIT | Amcon Distributing Co | Stock-Other | 1.03% | -0.40% | +5.05% | |
| 38 | CTSO | Cytosorbents CORP | Stock-Other | 0.96% | -0.35% | +36.30% | |
| 39 | ELDN | Eledon Pharmaceuticals Inc | Stock-Other | 0.94% | -0.23% | — | |
| 40 | SWK | Stanley Black & Decker Inc | Stock-Industrials | 0.77% | -0.45% | EXIT | |
| 41 | LTRN | Lantern Pharma Inc | Stock-Other | 0.71% | +1.03% | — | |
| 42 | HRI | Herc Holdings Inc | Stock-Other | 0.67% | +0.54% | — | |
| 43 | HAS | Hasbro Inc | Stock-Consumer Disc | 0.62% | — | -50.00% | |
| 44 | NKTREUR | Nektar Therapeutics | Stock-Other | 0.55% | — | +6.67% | |
| 45 | ✓ | Femasys Inc | Stock-Other | 0.53% | — | — | |
| 46 | CRIS | Curis Inc | Stock-Other | 0.51% | +0.11% | +9.09% | |
| 47 | OSTX | Os Therapies Inc | Stock-Other | 0.46% | +0.01% | +172.62% | |
| 48 | DELL | Dell Technologies -c | Stock-Tech | 0.46% | — | — | |
| 49 | ELTX | Elicio Therapeutics Inc | Stock-Other | 0.34% | -0.22% | EXIT | |
| 50 | ✓ | Assertio Holdings Inc | Stock-Other | 0.32% | — | +18.75% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALCO | Alico Inc | — | NEW | New buy |
| 2 | TGB | Taseko Mines LTD | — | NEW | New buy |
| 3 | RLGT | Radiant Logistics Inc | — | NEW | New buy |
| 4 | RIGL | Rigel Pharmaceuticals Inc | — | NEW | New buy |
| 5 | PLPC | Preformed Line Products Co | — | NEW | New buy |
| 6 | AM6 | Amicus Therapeutics Inc | — | NEW | New buy |
| 7 | TALO | Talos Energy Inc | — | NEW | New buy |
| 8 | NMRK | Newmark Group Inc-class A | — | NEW | New buy |
| 9 | BGC | Bgc Group Inc-a | — | NEW | New buy |
| 10 | PD | Pagerduty Inc | — | NEW | New buy |
| 11 | FCX | Freeport-mcmoran Inc | — | NEW | New buy |
| 12 | INTT | Intest CORP | — | NEW | New buy |
| 13 | JAZZ | Jazz Pharmaceuticals plc | — | NEW | New buy |
| 14 | RBCAA | Republic Bancorp Inc-class A | — | NEW | New buy |
| 15 | OGN | Organon & Co | — | NEW | New buy |
| 16 | CGAU | Centerra Gold Inc | — | NEW | New buy |
| 17 | ARKO | Arko CORP | — | NEW | New buy |
| 18 | PK | Park Hotels & Resorts Inc | — | NEW | New buy |
| 19 | THFF | First Financial CORP | — | NEW | New buy |
| 20 | CLPT | Clearpoint Neuro Inc | — | NEW | New buy |
| 21 | ARKR | Ark Restaurants CORP | — | NEW | New buy |
| 22 | SABR | Sabre CORP | — | NEW | New buy |
| 23 | BB3 | Brookline Bancorp Inc | — | NEW | New buy |
| 24 | VTRS | Viatris Inc | — | NEW | New buy |
| 25 | EOLS | Evolus Inc | — | NEW | New buy |
| 26 | CHRS | Coherus Oncology Inc | — | NEW | New buy |
| 27 | IOVA | Iovance Biotherapeutics Inc | — | NEW | New buy |
| 28 | WBD | Warner Bros Discovery Inc | — | NEW | New buy |
| 29 | CYTK | Cytokinetics Inc | — | NEW | New buy |
| 30 | AVIR | Atea Pharmaceuticals Inc | — | NEW | New buy |
| 31 | COHU | Cohu Inc | — | NEW | New buy |
| 32 | HRTX | Heron Therapeutics Inc | — | NEW | New buy |
| 33 | COYA | Coya Therapeutics Inc | — | NEW | New buy |
| 34 | XOMA | Xoma Royalty Corporation | — | NEW | New buy |
| 35 | ACAD | Acadia Pharmaceuticals Inc | — | NEW | New buy |
| 36 | SVC | Service Properties Trust | — | NEW | New buy |
| 37 | DIT | Amcon Distributing Co | — | NEW | New buy |
| 38 | CTSO | Cytosorbents CORP | — | NEW | New buy |
| 39 | ELDN | Eledon Pharmaceuticals Inc | — | NEW | New buy |
| 40 | SWK | Stanley Black & Decker Inc | — | NEW | New buy |
| 41 | LTRN | Lantern Pharma Inc | — | NEW | New buy |
| 42 | HRI | Herc Holdings Inc | — | NEW | New buy |
| 43 | HAS | Hasbro Inc | — | NEW | New buy |
| 44 | NKTREUR | Nektar Therapeutics | — | NEW | New buy |
| 45 | ✓ | Femasys Inc | — | NEW | New buy |
| 46 | CRIS | Curis Inc | — | NEW | New buy |
| 47 | OSTX | Os Therapies Inc | — | NEW | New buy |
| 48 | DELL | Dell Technologies -c | — | NEW | New buy |
| 49 | ELTX | Elicio Therapeutics Inc | — | NEW | New buy |
| 50 | ✓ | Assertio Holdings Inc | — | NEW | New buy |
According to official SEC Form 13F filings, CM Management, LLC reported a total U.S. public equity portfolio value of $157.4M across 54 disclosed positions in Q1 2025.
During Q1 2025, CM Management, LLC's top holdings by market value included ALCO (6.8%)、TGB (5.5%)、RLGT (4.8%). The largest single position, ALCO, represented 6.8% of total portfolio value.
In Q1 2025, CM Management, LLC made 54 total portfolio adjustments, initiating 54 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.